[1]马同敏,赵志强.血清CA125,STIP1和IGF-Ⅰ联合检测对卵巢癌的早期诊断价值研究[J].现代检验医学杂志,2018,33(06):50-54+58.[doi:10.3969/j.issn.1671-7414.2018.06.013]
　MA Tong-min,ZHAO Zhi-qiang.Clinical Value of Combined Detection of Serum CA125,STIP1 and IGF-I Levels in Early Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):50-54+58.[doi:10.3969/j.issn.1671-7414.2018.06.013]
点击复制

血清CA125,STIP1和IGF-Ⅰ联合检测对卵巢癌的早期诊断价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年06期
页码:
50-54+58
栏目:
论著
出版日期:
2018-12-24

文章信息/Info

Title:
Clinical Value of Combined Detection of Serum CA125,STIP1 and IGF-I Levels in Early Diagnosis of Ovarian Cancer
文章编号:
1671-7414(2018)06-050-06
作者:
马同敏1; 赵志强2
1.山东枣庄矿业集团中心医院检验科,山东枣庄 277000; 2.山东煤炭卫生学校,山东枣庄 277000
Author(s):
MA Tong-min1; ZHAO Zhi-qiang2
1.Department of Clinical Laboratory,Shandong Zaozhuang Mining Group Central Hospital,Shandong Zaozhuang 277000,China; 2.Shandong Coal Health School,Shandong Zaozhuang 277000,China
关键词:
卵巢癌;  早期诊断;  糖类抗原125;  磷酸化应激诱导蛋白1;  胰岛素样生长因子-Ⅰ
分类号:
R737.31; R730.43
DOI:
10.3969/j.issn.1671-7414.2018.06.013
文献标志码:
A
摘要:
目的 探讨血清糖类抗原125(carbohydrate antigen 125,CA125),磷酸化应激诱导蛋白1(stress-induced phosphoprotein 1,STIP1)和胰岛素样生长因子-Ⅰ(insulinlike growth factor-Ⅰ,IGF-Ⅰ)联合检测对卵巢癌的早期诊断价值。方法 枣庄矿业集团中心医院于2015年11月～2017年11月期间收治的经手术病理证实的90例卵巢癌患者作为卵巢癌组,同期该院收治的40例良性卵巢肿瘤患者作为卵巢良性肿瘤组,同期来该院体检的40例健康妇女作为健康组,检测血清CA125,STIP1和IGF-Ⅰ水平,对比三者单独及联合诊断卵巢癌的效果。结果 卵巢癌组、卵巢良性肿瘤组、健康组血清CA125水平分别为680.2±96.5,20.4±2.9和11.4±1.9 U/ml,血清STIP1水平为5.06±1.07,2.02±1.05和1.03±0.92 ng/ml,血清IGF-Ⅰ为120.4±32.4,215.4±34.3和190.3±45.6 ng/ml,经多个均数之间两两比较的q检验比较,卵巢癌组血清CA125,STIP1和IGF-Ⅰ水平与卵巢良性肿瘤组、健康组间差异具有统计学意义(q=14.319～70.632,均P<0.001); 血清CA125,STIP1和IGF-Ⅰ单独检测诊断卵巢癌的ROC曲线下面积分别为0.715,0.748和0.781,最佳诊断临界值为35 U/ml,3.2 ng/ml和174.5 ng/ml,三者单独检测诊断卵巢癌的敏感度为78.9%,86.7%和75.6%,特异度为72.5%,57.5%和63,8%,准确度为75.9%,72.9%和70.0%,卡方检验显示差异无统计学意义(χ2=2.345～3.971,均P>0.05); CA125+STIP1,CA125+STIP1+IGF-I平行联合诊断卵巢癌的ROC曲线下面积为0.812和0.854,诊断敏感度为90.0%和96.7%,特异度为60.0%和67.5%,准确度为75.9%和82.9%,卡方检验显示差异无统计学意义(χ2=0.974,3.073,P>0.05); CA125+STIP1,CA125+STIP1+IGF-I系列联合检测诊断卵巢癌的ROC曲线下面积为0.834和0.921,诊断特异度为81.3%和92.5%,准确度为75.9%和87.1%,组间比较差异具有统计学意义(χ2=4.440,7.033,P<0.05); CA125+STIP1+IGF-I系列联合检测诊断的特异度和准确度显著高于单独检测CA125,STIP1和IGF-Ⅰ(χ2=2.475～12.135,P<0.05)。结论血清CA125,STIP1和IGF-Ⅰ单独诊断卵巢癌敏感度和特异度较低,三者平行联合检测可提高诊断准确度,系列联合检测可提高特异度和准确度,有助于卵巢癌早期筛查和诊断。
Abstract:
Objective To explore the diagnostic value of combined detection of serum carbohydrate antigen 125(CA125),stress-induced phosphoprotein 1(STIP1)and insulinlike growth factor-Ⅰ(IGF-I)in early diagnosis of ovarian cancer.Methods 90 patients with ovarian cancer confirmed by pathology admitted from November 2015 to November 2017 were treated as ovarian cancerobservation group,40 patients with benign ovarian tumors admitted in the same periods were as ovarian benign tumor group 1,40 healthywomen examined in the same periods were as healthy.To measure the serum CA125,STIP1 and IGF-I level,and compared the diagnosis efficacy of all indexes aloneand jointly to diagnose ovarian cancer.Results The serum CA125 levels in ovarian cancerobservation group,varian benign tumor control,and healthy were 680.2±96.5,20.4±2.9 and 11.4±1.9 U/ml,and the serumSTIP1 level was 5.06±1.07,2.02±1.05 and 1.03±0.92 ng/ml,serum IGF-Iwas 120.4±32.4,215.4±34.3 and 190.3±45.6 ng/ml,respectively.The q test of the comparison of multiple mean comparisons showed that there was a statistically significant difference between observation group and the ovarian benign tumor group and healthy group(q=14.319～70.632,P<0.001).The areasunder ROC curve of serum CA125,STIP1 and IGF-I alone in the diagnosis of ovarian cancer were 0.715,0.748 and 0.781 respectively.The best diagnostic thresholds were 35 U/ml,3.2 ng/ml and 174.5 ng/ml.The sensitivity of the cancer was 78.9%,86.7% and 75.6%,the specificity was 72.5%,57.5% and 63.8%,the accuracy was 75.9%,72.9% and 70.0%.The chi-square test showed no statistically significant difference(χ2=2.345～3.971,all P>0.05).Thearea under the ROC curve of CA125+STIP1,CA125+STIP1+IGF-I parallel diagnosisof ovarian cancer was 0.812 and 0.854,the diagnostic sensitivity was 90.0% and 96.7%,the specificity was 60.0% and 67.5%,the accuracy was 75.9% and 82.9%,Chi-square test showed no significant difference(χ2=0.974,3.073,P> 0.05).CA125+STIP1,CA125+STIP1+IGF-I series of ovarian cancer under the ROC curve of the area of 0.834 and 0.921,thediagnostic specificity of 81.3% and 92.5%.The accuracy was 75.9% and 87.1%.The difference between the twogroups was statistically significant(χ2=4.440,7.033,all P<0.05).The specificity and accuracy of the combined diagnosis of CA125+STIP1+IGF-Iwere significantly higher than those of the two groups.Diagnosis of CA125,STIP1 and IGF-I(χ2=2.475～12.135,all P<0.05).ConclusionSerum CA125,STIP1 and IGF-I alone in diagnosis ovarian cancer hadlow sensitivity and specificity,the parallel diagnosis could improve diagnostic accuracy,the series diagnosis could improve diagnostic specificity and accuracy.It could help early screening and diagnosis for ovarian cancer.

参考文献/References:

[1] Merritt MA,Cramer DW.Molecular pathogenesis of endometrial andovarian cancer[J].Cancer Biomarkers,2011,9(1/6):287-305.
[2] Yeung TL,Leung CS,Yip KP,et al.Cellular and molecular processes in ovarian cancer metastasis.A review in the theme:cell and molecular processes incancer metastasis[J].American Journal of Physiology-Cell Physiology,2015,309(7):444-456.
[3] Solétormos G,Duffy MJ,Hassan SO,et al.Clinical use of cancer biomarkers in epithelial ovarian cancer:updated guidelines from the European group ontumor markers[J].International Journal of Gynecological Cancer,2016,26(1):43-51.
[4] Skates SJ,Greene MH,Buys SS,et al.Early detection of ovarian cancer using the risk of ovarian cancer algorithm with frequent CA125 testing in women at increased familial risk-combined results from two screening trials[J].Clinical Cancer Research,2017,23(14):3628-3637.
[5] Cho H,Kim S,Shin HY,et al.Expression of stress-induced phosphoprotein1(STIP1)is associated with tumor progression and poor prognosis in epithelialovarian cancer[J].Genes,Chromosomes and Cancer,2014,53(4):277-288.
[6] 郭玉琪,李保平,郭君红,等.肝细胞生长因子、胰岛素样生长因子-Ⅰ、基质金属蛋白酶-2在卵巢上皮性癌组织中的表达及其相关性[J].实用妇产科杂志,2016,32(10):742-746.
Guo YQ,Li BP,Guo JH,et al.The expression of HGF,IGF-Ⅰ and MMP-2 in epithelial ovarian cancer and accurate therapy in carcinoma[J].Journalof Practical Obstetrics and Gynecology,2016,32(10):742-746.
[7] Karanian-Philippe M,Velasco V,Longy M,et al.SM ARCA4(BRG1)loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type(ovarian rhabdoid tumor):a comprehensive analysis of 116 rare gynecologic tumors,9 soft tissue tumors,and 9 melanomas[J].AmericanJournal of Surgical Pathology,2015,39(9):1197-1205.
[8] Ou Y,Huang L,Huang Q,et al.Study on the clinical value of combined detection of HE4, CA199 and CA125 in diagnosis of ovarian cancer and benign ovarian cysts[J].International Journal of Laboratory Medicine,2015,13(18):2677-2678.
[9] Guo J,Yu J,Song X,et al.Serum CA125,CA199 and CEA combined detectionfor epithelial ovarian cancer diagnosis:A meta-analysis[J].Open Medicine,2017,12(1):131-137.
[10] 侯娟娟,虎淑妍,刘婷婷,等.血清肿瘤标志物在卵巢癌早期诊断中的临床价值[J].中国免疫学杂志,2014,30(8):1101-1104,1107.
Hou JJ,Hu SY,Liu TT,et al.Clinical value of serum tumor marker in early diagnosis ovarian cancer[J].Chinese Journal of Immunology,2014,30(8):1101-1104,1107.
[11] Barak V,Meirovitz A,Leibovici V,et al.The diagnostic and prognosticvalue of tumor markers(CEA,SCC,CYFRA 21-1,TPS)in head and neck cancer patients[J].Anticancer Research,2015,35(10):5519-5524.
[12] 高卫红,陶 岚,丁 丽.血清4项指标联合检测在卵巢癌早期诊断中的临床价值[J].国际检验医学杂志,2016,37(3):319-320,323.
Gao WH,Tao L,Ding L.Clinical value of combined detection of serum 4 indicators in diagnosis of ovarian cancer[J].International Journal of LaboratoryMedicine,2016,37(3):319-320,323.
[13] Angioli R,Miranda A,Aloisi A,et al.A critical review on HE4 performance in endometrial cancer:where are we now?[J].Tumor Biology,2014,35(2):881-887.
[14] 朱自力,戴伟萍,肖春红,等.血清HE4,CA125联合ROMA指数在卵巢癌预测和诊断中的应用价值[J].现代检验医学杂志,2014,29(2):76-77,80.
Zhu ZL,Dai WP,Xiao CH,et al.Value of combined assays of human epididymis protein4,CA125 and ROMA index in patients with ovarian cancer[J].Journalof Modern Laboratory Medicine,2014,29(2):76-77,80.
[15] 邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(6):37-40,43.
Xing RQ,Wu YC,Chen HY,et al.Diagnostic value of serum CA125,HE4 and ROMA index in patients with ovarian cancer[J].Journal of Modern Laboratory Medicine,2016,31(6):37-40,43.
[16] Chen Z,Xu L,Su T,et al.Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma[J].Biochemical and Biophysical Research Communications,2017,493(1):365-372.
[17] Chao A,Lee LY,Hsueh C,et al.Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen125 levels[J].Taiwanese Journal of Obstetrics and Gynecology,2013,52(2):185-191.
[18] 张月香,李秋丽,王承缙,等.外周血IGF-Ⅰ水平检测在卵巢癌诊断和疗效监测中的作用[J].中国癌症杂志,2014,24(11):874-877.
Zhang YX,Li QL,Wang CJ,et al.Effect of detection of peripheral blood IGF-I levels in ovarian cancer diagnosis and efficacy monitoring[J].China Oncology,2014,24(11):874-877.
[19] Schairer C,McCarty CA,Isaacs C,et al.Circulating insulin-like growth factor(IGF)-I and IGF binding protein(IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate,lung,colorectal,and ovarian cancer screeningtrial(PLCO)cohort[J].Hormones and Cancer,2010,1(2):100-111.
[20] Smith RA,Andrews K,Brooks D,et al.Cancer scre-ening in the United States,2016:a review of current American Cancer Society guidelines and currentissues in cancer screening[J].CA:A Cancer Journal for Clinicians,2016,66(2):95-114.

相似文献/References:

[1]唐海霞,王 成,路美玲,等.肾透明细胞癌患者血清miR-193a-3p水平增加及早期诊断价值[J].现代检验医学杂志,2015,30(03):43.[doi:10.3969/j.issn.1671-7414.2015.03.012]
　TANG Hai-xia,WANG Cheng,LU Mei-ling,et al.Elevated Serum miR-193a-3p Level in Renal Clear Cell Carcinoma and Its Early Clinical Value[J].Journal of Modern Laboratory Medicine,2015,30(06):43.[doi:10.3969/j.issn.1671-7414.2015.03.012]
[2]顾益凤,朱自力,张金业,等.利用ROC曲线选择血清HE-4对卵巢癌的最佳诊断界点[J].现代检验医学杂志,2015,30(04):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
　GU Yi-feng,ZHU Zi-li,ZHANG Jin-ye,et al.Selecting the Best Cut-off Point of Serum HE-4 in Ovarian Cancer by ROC Curve[J].Journal of Modern Laboratory Medicine,2015,30(06):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
[3]郑福利,张颖,王建.血清S100A6检测对卵巢上皮性癌的诊断价值[J].现代检验医学杂志,2015,30(05):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
　ZHENG Fu-li,ZHANG Ying,WANG Jian.Study on Diagnostic Value of Detecting Serum S100A6 in the Epithelial Ovarian Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(06):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
[4]詹颉,常宁宁,李小侠,等.CEA，AFP，CA125，CA199和CA72-4联合检测在鉴别卵巢良恶性疾病中的应用价值[J].现代检验医学杂志,2015,30(05):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
　ZHAN Jie,CHANG Ning-ning,LI Xiao-xia,et al.Clinical Value of Combined Detection of CEA，AFP，CA125，CA199 and CA72-4 in the Identification of Ovarian Benign and Malignant Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
[5]邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(06):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
　XING Rui-qing,WU Yong-chang,CHEN Hui-yu,et al.Diagnostic Value of Serum CA125,HE4 and ROMA Index in Patients with Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
[6]汪奇云,刘和录,华建江,等.血浆miR-142-5p在肺癌早期诊断中的价值研究[J].现代检验医学杂志,2016,31(06):74.[doi:10.3969/j.issn.1671-7414.2016.06.020]
　WANG Qi-yun,LIU He-lu,HUA Jian-jiang,et al.Value of Plasma miR-142-5p in the Early Diagnosis of Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(06):74.[doi:10.3969/j.issn.1671-7414.2016.06.020]
[7]朱文芳,沈建军,付 涛,等.血清GPDA联合肿瘤标志物对胃癌早期诊断的临床价值[J].现代检验医学杂志,2017,32(04):110.[doi:10.3969/j.issn.1671-7414.2017.04.031]
　ZHU Wen-fang,SHEN Jian-jun,FU Tao,et al.Clinical Value of Serum GPDA Associated Tumor Markers for Early Diagnosis of Gastric Cancer[J].Journal of Modern Laboratory Medicine,2017,32(06):110.[doi:10.3969/j.issn.1671-7414.2017.04.031]
[8]张 悦a,段海霞,暴 蕾a,等.microRNA-125b在葛根素诱导人卵巢癌细胞SKOV3凋亡中的作用研究[J].现代检验医学杂志,2017,32(05):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
　ZHANG Yuea,DUAN Hai-xia,BAO Leia,et al.Role of MicroRNA-125b in Human Ovarian Cancer Cell SKOV3 Induced Apoptosis by Puerarin[J].Journal of Modern Laboratory Medicine,2017,32(06):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
[9]徐金良a,杜丹丹,翟志敏,等.卵巢良恶性肿瘤患者血液NLR,LMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(02):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　XU Jin-lianga,DU Dan-dan,ZHAI Zhi-min,et al.Changes and Clinical Significance of Four Parameters of NLR,LMR, RDW and PLR in Patients with Benign and Malignant Ovarian Tumors[J].Journal of Modern Laboratory Medicine,2018,33(06):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[10]张善弟,荆成宝,禹 梅.血清CEA,CA125和HE4联合检测对卵巢癌的诊断价值[J].现代检验医学杂志,2018,33(06):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]
　ZHANG Shan-di,JING Cheng-bao,YU Mei.Clinical Value of Combined Detection of Serum CEA,CA125 and HE4 in the Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(06):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]

备注/Memo

备注/Memo:
作者简介:马同敏(1973-),女,本科,副主任技师,研究方向:免疫与肿瘤学检验。
更新日期/Last Update: 2018-11-30